Quarterly report pursuant to Section 13 or 15(d)

Warrants And Options

v3.8.0.1
Warrants And Options
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Note 8 - Warrants and Options

a) Warrants

 

See Note 7.

 

The following table summarizes the changes in warrants outstanding of the Company during the nine-month period ended September 30, 2017:

 

    Number of Warrants    

Weighted Average

Exercise Price
($)

 
Outstanding at December 31, 2016     2,162,638       2.40  
Granted     -       -  
Exercised     (392,651 )     (2.38 )
Expired     (38,307 )     (2.40 )
Outstanding at September 30, 2017     1,731,680       2.36  
                 
Exercisable at September 30, 2017     1,606,680       2.35  

 

On February 14, 2017, the Company modified the performance criteria for a vesting milestone on an employee warrant agreement and as a result the Company re-measured warrants held by an employee, to purchase 25,000 shares of common stock at an exercise price of $2.47 per share. These warrants vest on achievement of certain business objectives and expire 3 years from the date of vesting. The Company has calculated the estimated fair market value of these warrants using the Black-Scholes model and the following assumptions: term: 0.5 years, stock price: $4.52, exercise price: $2.47, 55.65% volatility, 0.66% risk free rate.

 

On May 10, 2017, 28,307 warrants expired and on September 5, 2017, 10,000 warrants expired.

 

Effective August 22, 2017, the Company amended the expiry period of 24,000 warrants, originally granted on September 26, 2014. The expiration period was extended from three to four years for all 24,000 warrants, with their new expiration date being September 26, 2018. The Company recalculated the estimated fair market value of these warrants using the Black-Scholes model, but the result was deemed to be immaterially different to the original calculation and the financial statements were not adjusted.

 

Effective August 22, 2017, the Company amended the expiry period of 19,000 warrants, originally granted on November 17, 2014. The expiration period was extended from three to four years for all 19,000 warrants, with their new expiration date being November 17, 2018. The Company recalculated the estimated fair market value of these warrants using the Black-Scholes model, but the result was deemed to be immaterially different to the original calculation and the financial statements were not adjusted.

 

Below is a table summarizing the warrants issued and outstanding as of September 30, 2017, which have a weighted average exercise price of $2.36 per share and an aggregate weighted average remaining contractual life of 1.55 years.

 

Date Issued   Number Outstanding     Number Exercisable     Exercise Price ($)     Contractual Life (Years)     Weighted Average Remaining Contractual Life (Years)     Expiration Date   Proceeds to Company if Exercised ($)  
03/20/13     125,000       -       2.47     8.0 to 9.0       0.26     06/30/20 to 12/31/21     308,750  
03/20/13     25,000       25,000       2.47       7.5       0.06     09/18/20     61,750  
06/10/13     29,750       29,750       2.00       5.0       0.01     06/10/18     59,500  
11/25/13     456,063       456,063       2.40       5.0       0.30     11/25/18     1,094,551  
12/31/13     64,392       64,392       2.40       5.0       0.05     12/31/18     154,541  
02/26/14     948,475       948,475       2.20       5.0       0.77     02/26/19     2,086,645  
09/26/14     24,000       24,000       3.00       3.0       0.01     09/26/18     72,000  
11/17/14     19,000       19,000       3.75       3.0       0.01     11/17/18     71,250  
11/14/16     40,000       40,000       4.53       4.0       0.07     11/14/20     181,200  
      1,731,680       1,606,680                       1.55         $ 4,090,187  

 

Total remaining unrecognized compensation cost related to non-vested warrants is approximately $41,324 and is expected to be recognized over a period of 1.3 years. As of September 30, 2017, the total intrinsic value of warrants was $570,291.

 

b) Options

 

The following table summarizes the changes in options outstanding of the Company during the nine-month period ended September 30, 2017:

 

    Number of
Options
   

Weighted Average

Exercise Price
($)

 
Outstanding at December 31, 2016     2,384,300       3.75  
Granted     871,000       4.99  
Exercised     -       -  
Expired     (211,000 )     (4.05 )
Outstanding at September 30, 2017     3,044,300       4.08  
                 
Exercisable at September 30, 2017     2,173,300       3.72  

 

Effective January 1, 2017, the Company granted stock options to purchase 50,000 shares of common stock. These options vest on January 1, 2018 and expire 5 years after the vesting date, with an exercise price of $4.80 per share. The Company has calculated the estimated fair market value of these options at $157,890, using the Black-Scholes model and the following assumptions: term 6 years, stock price $4.57, exercise price $4.80, 80.70% volatility, 2.26% risk free rate.

 

Effective February 13, 2017, the Company granted stock options to purchase 25,000 shares of common stock. These options vest on February 13, 2018 and expire 5 years after the vesting date, with an exercise price of $5.00 per share. The Company has calculated the estimated fair market value of these options at $76,773, using the Black-Scholes model and the following assumptions: term 6 years, stock price $4.52, exercise price $5.00, 80.17% volatility, 2.24% risk free rate.

 

On March 1, 2017, stock options to purchase 5,000 shares of common stock expired unexercised.

 

On March 30, 2017, the Company granted stock options to purchase 686,000 shares of common stock. These options vest on March 30, 2018 and expire five years after their vesting date, with an exercise price of $5.00 per share. The Company has calculated the estimated fair market value of these options at $1,898,322, using the Black-Scholes model and the following assumptions: term 6 years, stock price $4.18, exercise price $5.00, 79.41% volatility, 2.25% risk free rate.

 

Effective April 10, 2017, the Company granted stock options to purchase 100,000 shares of common stock. These options vest on April 10, 2018 and expire 5 years after the vesting date, with an exercise price of $5.00 per share. The Company has calculated the estimated fair market value of these options at $258,077, using the Black-Scholes model and the following assumptions: term 6 years, stock price $3.96, exercise price $5.00, 79.33% volatility, 2.18% risk free rate.

 

On May 25, 2017, stock options to purchase 101,000 shares of common stock expired unexercised.

 

On May 31, 2017, stock options to purchase 25,000 shares of common stock expired unexercised.

 

Effective July 13, 2017, the Company granted stock options to purchase 10,000 shares of common stock. These options vest on July 13, 2018 and expire 5 years after the vesting date, with an exercise price of $5.00 per share. The Company has calculated the estimated fair market value of these options at $19,068, using the Black-Scholes model and the following assumptions: term 6 years, stock price $3.15, exercise price $5.00, 78.41% volatility, 2.16% risk free rate.

 

Effective August 14, 2017, the Company amended the expiry period of stock options to purchase 37,000 shares of common stock, which options were originally granted on March 20, 2013 and amended on June 27, 2016. The expiration period was extended from four to six years, with the outside expiration date of March 20, 2022, after vesting for all 37,000 stock options. The Company recalculated the estimated fair market value of these options using the Black-Scholes model, but the result was deemed to be immaterially different to the original calculation and the financial statements were not adjusted.

 

Effective August 14, 2017, the Company amended the expiry period of stock options to purchase 16,300 shares of common stock, which options were originally granted on September 2, 2013 and amended on June 27, 2016. The expiration period was extended from four to six years, with the outside expiration date of September 2, 2022, after vesting for all 16,300 stock options. The Company recalculated the estimated fair market value of these options using the Black-Scholes model, but the result was deemed to be immaterially different to the original calculation and the financial statements were not adjusted.

 

On August 31, 2017, stock options to purchase 75,000 shares of common stock expired unexercised.

 

On September 1, 2017, stock options to purchase 5,000 shares of common stock expired unexercised.

 

On September 8, 2017, an amendment to the 2015 Stock Incentive Plan (the “2015 Plan”) was approved by stockholders at the annual meeting to increase the number of shares of common stock available for issuance under the 2015 Plan by 750,000 shares to an aggregate maximum of 2,500,000 shares.

 

Below is a table summarizing the options issued and outstanding as of September 30, 2017, all of which were issued pursuant to the 2011 Equity Incentive Plan (for option issuances prior to 2016) or the 2015 Plan (for option issuances commencing in 2016) and which have a weighted average exercise price of $4.08 per share and an aggregate weighted average remaining contractual life of 3.56 years.

 

Date Issued   Number Outstanding     Number
Exercisable
    Exercise
Price
($)
    Contractual Life (Years)    

Weighted

Average

Remaining Contractual Life (Years)

    Expiration
Date
  Proceeds to Company if Exercised
($)
 
11/25/11     303,000       303,000       4.00-5.00       6.0-7.0       0.06     11/25/17-11/25/18     1,414,000  
09/01/12     10,000       10,000       6.31       6.0       0.00     03/01/18-09/01/18     63,100  
03/20/13     37,000       37,000       2.35-4.35       6.5-9.0       0.04     09/20/19-03/20/22     123,950  
09/02/13     16,300       16,300       2.35-4.35       6.5-9.0       0.02     03/02/20-09/02/22     54,605  
05/16/14     25,000       25,000       3.00-5.00       3.5-6.0       0.01     11/16/17-05/16/20     100,000  
08/18/14     645,000       645,000       2.50 and 3.00       4.5 and 5.5       0.40     02/18/19-02/18/20     1,773,750  
05/18/15     20,000       20,000       3.80       4.5       0.01     11/18/19     76,000  
07/23/15     317,000       317,000       4.00       4.5       0.25     01/23/20     1,268,000  
04/15/16     775,000       775,000       4.00       6.0       1.16     04/15/22     3,100,000  
06/23/16     15,000       15,000       4.00       6.0       0.02     06/23/22     60,000  
11/11/16     10,000       10,000       5.00       6.0       0.02     11/11/22     50,000  
01/01/17     50,000       -       4.80       6.0       0.09     01/01/23     240,000  
02/13/17     25,000       -       5.00       6.0       0.04     02/13/23     125,000  
03/30/17     686,000       -       5.00       6.0       1.24     03/30/23     3,430,000  
04/10/17     100,000       -       5.00       6.0       0.18     04/10/23     500,000  
07/13/17     10,000       -       5.00       6.00       0.02     07/13/23     50,000  
      3,044,300       2,173,300                       3.56           12,428,405  

 

Total remaining unrecognized compensation cost related to non-vested stock options is approximately $1,160,892 and is expected to be recognized over a period of 1.0 years. As of September 30, 2017, the total intrinsic value of stock options was $46,900.